Moderna Says European Patent Office Decided To Maintain Validity Of Co's EP949 Patent, One Of The Key Patents Currently Asserted Against Pfizer & BioNTech In Various European National Courts
Moderna Says European Patent Office Decided To Maintain Validity Of Co's EP949 Patent, One Of The Key Patents Currently Asserted Against Pfizer & BioNTech In Various European National Courts
Moderna 表示，歐洲專利局決定維持公司的 EP949 專利的有效性，這是目前在多個歐洲國家法院針對輝瑞和 BioNTech 主張的關鍵專利之一
Moderna Says European Patent Office Decided To Maintain Validity Of Co's EP949 Patent, One Of The Key Patents Currently Asserted Against Pfizer & BioNTech In Various European National Courts
Moderna 表示，歐洲專利局決定維持公司的 EP949 專利的有效性，這是目前在多個歐洲國家法院針對輝瑞和 BioNTech 主張的關鍵專利之一
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。